Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Decoding enhancer usage and gene expression of human heart development in 3-D cardioids

Project description

In a heartbeat, tracked by cardioids

In early heart development, a complex, intricate network of transcription factors controls the development of a beating heart tube by activating regulatory elements, called heart enhancers that integrate signals from surrounding tissues. How this process is controlled is still a mystery and how mutations in heart enhancers result in cardiomyopathies remains unclear. The EU-funded 3-D Cardioid project will use cardioids and state-of-the-art heart organoids, derived from human induced pluripotent stem cells. For the first time in these in vitro models, single cell genomic approaches will be applied at different stages to map human heart development and gene regulation during cardiogenesis.

Objective

The early steps of heart formation during embryogenesis require precise spatiotemporal coordination between different heart progenitors to join together to form a beating heart tube. This complex biological process is regulated through an evolutionary conserved gene regulatory network (GRN) of transcription factors and cis-regulatory elements that integrate inductive signals from surrounding tissues to ensure correct heart development. Yet, how this process is controlled during heart development, and how mutations impacting the cardiac GRN leads to cardiomyopathies, remains unclear. There is currently little or no information about human heart enhancers during these early stages of heart development. Here, we will first determine the dynamic changes in the usage of regulatory elements and gene expression that accompanies human heart development using heart organoids (cardioids) derived from human induced pluripotent stem cells. To uncover the underlying GRN, we will apply scRNA-seq and scATAC-seq to 3-D cardioids at different stages of development, which will allow us to map enhancer usage during cell fate transitions in human heart development for the first time in vitro. Moreover, we will study how developmental trajectories are altered in disease-relevant mutant 3-D cardioids models. Last, we will study how perturbations of transcription factors influence enhancer function and gene expression by fine-tuning the nuclear level of key regulators using an optogenetic tool developed by the Furlong lab, which is extremely dynamic providing very precise temporal resolution, in the order of minutes. The functional impact of these perturbations will be assessed by scRNA-seq and scATAC-seq to identify the transcription factors’ regulatory mechanisms. Together, these findings will advance our understanding of gene regulation during cardiogenesis by identifying fundamental principles of enhancer usage and transcriptional changes during normal and diseased heart development.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2021-PF-01

See all projects funded under this call

Coordinator

EUROPEAN MOLECULAR BIOLOGY LABORATORY
Net EU contribution
€ 189 687,36
Address
Meyerhofstrasse 1
69117 Heidelberg
Germany
Region
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Activity type
Research Organisations
Links
Total cost
No data